Graphite Bio, Inc.
SEC Filing List
GRPH CIK: 0001815776
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Lenz Therapeutics, Inc. | 05/11/2026 | ||
| 8-K | Current report filing | Lenz Therapeutics, Inc. | 05/11/2026 | ||
| DEF 14A | Definitive proxy statements | Lenz Therapeutics, Inc. | 04/28/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Lenz Therapeutics, Inc. | 04/28/2026 | ||
| ARS | Annual report to security holders | Lenz Therapeutics, Inc. | 04/28/2026 | ||
| SCHEDULE 13G | 04/27/2026 | ||||
| SCHEDULE 13G | 04/08/2026 | ||||
| 4 | Statement of changes in beneficial owner... | George Jeffrey P. | Lenz Therapeutics, Inc. | 03/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Chevallard Daniel R. | Lenz Therapeutics, Inc. | 03/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Schimmelpennink Evert B. | Lenz Therapeutics, Inc. | 03/30/2026 | |
| No record found. | |||||
| Load More | |||||
